XML 56 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION AND INCENTIVE PLANS (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of Common Stock Shares Reserved for Issuance and Shares Available for Grant

The number of common stock shares reserved for issuance under the plans and the number of shares available for future grants are as follows:

 

     Successor      Predecessor  
     Period from
August 1,
2017 through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
     Year Ended
March 31,
2017
 

Shares of common stock reserved for issuance under the plans

     3,048,877        —          1,900,769  

Shares of common stock available for future grants

     1,891,231        —          505,221  
Fair Value and Assumptions Used for Stock Options Issued

The fair value and assumptions used for the stock options issued during the years ended March 31, 2016 and 2015 are as follows:

 

     2016     2015  

Weighted average fair value of stock options granted

   $ 3.34     $ 5.54  

Risk-free interest rate

     1.62     1.82

Expected dividend yield

     0.0     0.0

Expected stock price volatility

     45     30

Expected stock option life

     6.5 years       6.5 years  
Schedule of Stock Option Activity

The following table sets forth a summary of stock option activity of the company:

 

     Weighted-
average
Exercise
Price
     Number of
Shares
 

Outstanding at March 31, 2016 (Predecessor)

   $ 31.73        1,777,124  

Granted

     —          —    

Exercised

     —          —    

Expired or cancelled/forfeited

     44.86        (381,576
  

 

 

    

 

 

 

Outstanding at March 31, 2017 (Predecessor)

     28.14        1,395,548  

Granted

     —          —    

Exercised

     —          —    

Expired or cancelled/forfeited

     28.14        (1,395,548
  

 

 

    

 

 

 

Outstanding at July 31, 2017 (Predecessor)

     —          —    

Granted

     —          —    

Exercised

     —          —    

Expired or cancelled/forfeited

     —          —    
  

 

 

    

 

 

 

Outstanding at December 31, 2017 (Successor)

   $ —          —    
  

 

 

    

 

 

Additional Information Regarding Stock Options

Additional information regarding stock options is as follows:

 

     Successor      Predecessor  

(In thousands, except number of stock options and

weighted average price)

   Period from
April 1, 2017
through
December 31,
2017
     Period from
August 1, 2017
through
July 31,
2017
     Year Ended
March 31,
2017
 

Intrinsic value of options exercised

     —          —          —    

Number of stock options vested

     —          —          266,311  

Fair value of stock options vested

   $ —          —          1,185  

Number of options exercisable

     —          —          999,849  

Weighted average exercise price of options exercisable

   $ —          —          34.36  
Effect on Basic and Diluted Earnings Per Share, and Stock Option Compensation Expense

Stock option compensation expense along with the reduction effect on basic and diluted earnings per share are as follows:

 

     Successor      Predecessor  

(In thousands, except per share data)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
     Year Ended
March 31,
2017
 

Stock option compensation expense

   $ —          1,644        745  

Basic loss per share increased by

     —          0.02        0.02  

Diluted loss per share increased by

     —          0.02        0.02  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Restricted stock unit compensation expense and grant date fair value are as follows:

 

     Successor      Predecessor  

(In thousands)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31, 2017
     Year Ended
March 31,
2017
 

Grant date fair value of restricted stock units vested

   $ —          10        3,754  

Restricted stock unit compensation expense

     3,731        2        2,425  
Summary of Phantom Stock Activity

The following table sets forth a summary of phantom stock activity of the company:

 

    Weighted-
average
Grant-Date
Fair Value
    Time
Based
Shares
    Weighted-
average
Grant-Date
Fair Value
    Series A
Warrants
    Weighted-
average
Grant-Date
Fair Value
    Series B
Warrants
 

Non-vested balance at March 31, 2016 (Predecessor)

  $ 10.83       1,599,829          

Granted

    —         —            

Vested

    12.29       (585,426        

Cancelled/forfeited

    13.52       (68,253        
 

 

 

   

 

 

         

Non-vested balance at March 31, 2017 (Predecessor)

    9.74       946,150          

Granted

    —         —            

Vested

    —         —            

‘Cancelled (A)

    9.70       (484,446        

Forfeited

    10.08       (16,866        
 

 

 

   

 

 

         

Non-vested balance at July 31, 2017 (Predecessor) (B)

    9.77       444,838          
 

 

 

   

 

 

         

Issuance of Successor phantom stock (B)

    308.19       14,160       1.00       22,963       0.98       24,824  

Balance at August 1, 2017

    —         —            

Granted

    —         —            

Vested

    —         —            

Cancelled/forfeited

    307.31       (634     1.00       (1,029     0.98       (1,112
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-vested balance at December 31, 2017 (Successor)

  $ 308.24       13,526       1.00       21,934       0.98       23,712  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(A)

Prior to emergence from Chapter 11 bankruptcy, all officer-held phantom stock units were cancelled. Refer to Item 7. “Reorganization and Chapter 11 Proceedings.”

(B)

Upon emergence from Chapter 11 bankruptcy, all outstanding phantom stock units held by non-officer employees were converted by the same conversion ratio applied to the common shares upon emergence. Every 31.4143 phantom stock units converted into one phantom stock unit post emergence which is valued to the new common stock. In addition, each post emergence phantom stock unit received 1.6216 phantom series A warrants and 1.7531 phantom series B warrants. Both warrant series have time-based vesting and follow the vesting schedule of the underlying phantom stock unit. Refer to Item 7. “Reorganization and Chapter 11 Proceedings.”

Summary of Cash-Based Performance Plan Unit Activity

The following table sets forth a summary of cash-based performance plan unit activity of the company:

 

     Weighted-
average
Grant-Date
Fair Value
     Performance
Based
Units
 

Non-vested balance at March 31, 2016 (Predecessor)

   $ 1.16        7,913,716  

Granted

     —          —    

Vested

     —          —    

Cancelled/forfeited

     1.15        (179,991
  

 

 

    

 

 

 

Non-vested balance at March 31, 2017 (Predecessor)

     1.16        7,733,725  

Granted

     —          —    

Vested

     —          —    

Cancelled/forfeited

     1.16        (7,733,725
  

 

 

    

 

 

 

Non-vested balance at July 31, 2017 (Predecessor)

     —          —    
  

 

 

    

 

 

Summary of Deferred Stock Unit Activity

The following table sets forth a summary of deferred stock unit activity of the company:

 

     Weighted-
average
Grant-Date
Fair Value
     Number
Of
Units
 

Balance at March 31, 2016 (Predecessor)

   $ 23.58        363,630  

Dividend equivalents reinvested

     —          —    

Retirement distribution

     6.83        (12,792

Granted

     —          —    
  

 

 

    

 

 

 

Balance at March 31, 2017 (Predecessor)

     24.19        350,838  

Dividend equivalents reinvested

     —          —    

Retirement distribution

     24.19        (350,838

Granted

     —          —    
  

 

 

    

 

 

 

Balance at July 31, 2017 (Predecessor)

     —          —    
  

 

 

    

 

 

Schedule of Deferred Cash Award Expense

Deferred cash award expense, which is reflected in general and administrative expenses, is as follows:

 

     Successor      Predecessor  

(In thousands)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
     Year Ended
March 31,
2017
 

Deferred cash award expense

   $ —          12        978  
Deferred Stock Unit  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Deferred stock unit compensation expense, which is reflected in general and administrative expenses, is as follows:

 

     Successor      Predecessor  

(In thousands)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
    Year Ended
March 31,
2017
 

Deferred stock units compensation expense (benefit)

   $ —          (68     (1,987
Restricted Stock Units (RSUs)  
Summary Of Restricted Stock Unit Activity

The following table sets forth a summary of restricted stock unit activity of the company:

 

     Weighted-
average
Grant-Date
Fair Value
     Time
Based
Units
    Weight-
average
Grant Date
Fair Value
     Performance
Based Units
 

Non-vested balance at March 31, 2016 (Predecessor)

   $ 49.17        89,639       61.75        156,851  

Granted

     —          —         —          —    

Vested

     49.39        (76,006     —          —    

Cancelled/forfeited

     49.62        (13,450     61.75        (156,851
  

 

 

    

 

 

   

 

 

    

 

 

 

Non-vested balance at March 31, 2017 (Predecessor)

     54.48        183       —          —    

Granted

     —          —         —          —    

Vested

     54.48        (183     —          —    

Cancelled/forfeited

     —          —         —          —    
  

 

 

    

 

 

   

 

 

    

 

 

 

Non-vested balance at July 31, 2017 (Predecessor)

     —          —         —          —    

Granted

     24.40        1,203,379       —          —    

Vested

     —          —         —          —    

Cancelled/forfeited

     24.15        (45,733     —          —    
  

 

 

    

 

 

   

 

 

    

 

 

 

Non-vested balance at December 31, 2017 (Successor)

   $ 24.41        1,157,646       —          —    
  

 

 

    

 

 

   

 

 

    

 

 

Phantom Stock Plan  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Phantom stock compensation expense and grant date fair value of phantom stock vested are as follows:

 

     Successor      Predecessor  

(In thousands)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
     Year Ended
March 31,
2017
 

Grant date fair value of phantom stock vested

   $ —          —          7,118  

Phantom stock compensation expense

     94        68        467  
Cash-based Performance Plan  
Schedule of Restricted Stock Compensation Expense and Grant Date Fair Value

Cash-based performance unit compensation expense and grant date fair value are as follows:

 

     Successor      Predecessor  

(In thousands)

   Period from
August 1, 2017
through
December 31,
2017
     Period from
April 1, 2017
through
July 31,
2017
    Year Ended
March 31,
2017
 

Grant date fair value of cash-based performance units vested

   $ —          —         —    

Cash-based performance unit compensation expense

     —          (1,975     761